Safety Study in Subjects With Leber Congenital Amaurosis
Clinical trial NCT00516477 · COMPLETED
Trial details
- NCT number
- NCT00516477
- Sponsor
- Spark Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2018-03-20
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.